Amgen
AMGN
NASDAQ
IPO1983
about AMGN
Amgen is a biotechnology company that develops innovative medicines to treat serious diseases, utilizing cutting-edge scientific research and technological advancements to improve patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $372.01 | $377.00 | $371.39 | $202.0B | 2.91M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$5.98 | 22.02 | 21.23 | 26.43% | 33.65% | 2.69% |